UPDATE : Monday, September 7, 2020
상단여백
SNUH opens new Covid-19 treatment center in 2 days
Seoul National University Hospital (SNUH) said Thursday that it opened a la...
by Shim Hyun-tai  |  2020-08-27 18:06
라인
Genexine's cytokine drug effective on severe Covid-19 patients
Genexine said Thursday that it has confirmed the safety and efficacy of lon...
by Shim Hyun-tai  |  2020-08-27 18:05
라인
Korea publishes guidelines for digital therapeutics
The Ministry of Food and Drug Safety has published the guidelines for winni...
by Kim Yun-mi  |  2020-08-27 18:05
라인
Drugmakers to sue government for limiting choline alfoscerate benefit
Manufacturers of choline alfoscerate, a dementia drug, are reportedly prepa...
by Kim Yun-mi  |  2020-08-27 14:26
라인
Stocks of 3 Covid-19 vaccine developers spike
Three Korean drugmakers working on a Covid-19 vaccine have garnered robust ...
by Kim Chan-hyuk  |  2020-08-27 14:07
라인
New virus cases reach six-month high; tightest restrictions imminent
Korea reported new Covid-19 cases of more than 400 for the first time in si...
by Shim Hyun-tai  |  2020-08-27 13:24
라인
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
A joint research team of Helixmith and Seoul National University College of...
by Shim Hyun-tai  |  2020-08-26 17:47
라인
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clini...
by Shim Hyun-tai  |  2020-08-26 17:17
라인
‘Stringent social distancing can calm Covid-19 in early September’
The nation’s daily new cases of Covid-19 rebounded to exceed 300 on Wednesd...
by Song Soo-youn  |  2020-08-26 16:25
라인
Why medical school students give up pursuing public health jobs
A total of 2,811 seniors of the six-year medical colleges and the four-year...
by Song Soo-youn  |  2020-08-26 16:21
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
HK inno.N has teamed up with T&R Biofab to test the efficacy of its skin di...
by Shim Hyun-tai  |  2020-08-26 16:19
라인
Virus cases rebound above 300, pushing nation closer to tightest restrictions
Korea’s new Covid-19 cases climbed back above 300 Wednesday, stepping up pr...
by Shim Hyun-tai  |  2020-08-26 13:35
라인
Novartis fails trial on skin cancer drug candidate spartalizumab
Novartis said it its phase-3 trial on immunotherapy spartalizumab, a progra...
by Kim Yun-mi  |  2020-08-26 11:11
라인
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
CrystalGenomics said Monday that the U.S. Food and Drug Administration has ...
by Shim Hyun-tai  |  2020-08-25 17:07
라인
[Column] How ongoing doctors’ strike is different from 20 years ago
The recent series of strikes by physicians are different from those two dec...
by Park Jae-young Executive editor  |  2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
PharmAbcine, a bio company specializing in antibody therapies, said Tuesday...
by Shim Hyun-tai  |  2020-08-25 16:57
라인
Huons' eye drop wins Saudi’s regulatory nod
Huons' flagship eye drop product entered the Saudi Arabia market, signa...
by Shim Hyun-tai  |  2020-08-25 14:50
라인
New virus cases below 300 for 2nd day but spreads continue
Korea saw new Covid-19 cases of below 300 for the second day on Tuesday but...
by Shim Hyun-tai  |  2020-08-25 11:51
라인
Drugmakers in active open innovation with startups
The local pharmaceutical industry is increasingly seeking “open innovation,...
by Kim Chan-hyuk  |  2020-08-25 11:51
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
HK inno.N has published the results of phase 3 clinical trial of gastroesop...
by Shim Hyun-tai  |  2020-08-24 18:02
여백
여백
여백
Back to Top